110020 — Jeonjin Bio Co Cashflow Statement

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Jeonjin Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3,418	-2,108	-3,154	-6,440	4,346
Depreciation
Amortisation
Non-Cash Items	1,640	-629	157	5,282	-3,088
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-972	-14.3	-2,105	-979	406
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-2,310	-2,385	-3,710	-301	3,005
Capital Expenditures	-5,837	-1,933	-2,129	-672	-394
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.82	75	-2,177	638	1,149
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities	-5,836	-1,858	-4,306	-33.5	755
Financing Cash Flow Items	-196	-30.9	-726	-689	-667
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	12,909	10,629	-5,928	694	811
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4,760	6,383	-13,971	358	4,583